FDA issued a Warning Letter to Valeant Pharmacueticals International on 11/3/2016 for a later inspection.
483 Valeant Pharmacueticals North America Jun 2014

483 Valeant Pharmacueticals North America Jun 2014

Frank Marciniak FDA$119.00 - Available Now

FDA investigators audited the Valeant Pharmacueticals North America - Rochester, NY, United States facility and issued inspectional observations (via FDA 483) on 26 Jun 2014.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 26 Jun 2014
  • Location: Rochester, United States
  • FEI: 3009443653
Add To Cart